About Adam Craig
Adam Craig is an executive chairman at X4 Pharmaceuticals.
Form D filings name Adam Craig as a president and CEO at Garuda Therapeutics and sits on its board.
Adam Craig reports to the SEC as a director or officer of 4 public companies, including Cti Biopharma (CTIC), Viracta Therapeutics (VIRX) and CytRx Oncology (IVPH.OB).
Adam Craig first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Adam Craig in the role, so the role may have started earlier or lasted longer.
XI
X4 Pharmaceuticals, Inc
Executive Chairman
2025 – 2026 · Public company (XFOR)
CC
Cti Biopharma Corp.
President and CEO, director
2017 – 2023 · Public company (CTIC)
VI
Viracta Therapeutics, Inc.
EVP, Development & CMO
2012 – 2015 · Public company (VIRX)
CC
CytRx Oncology Corp
VP and Chief Medical Officer
2006 – 2007 · Public company (IVPH.OB)
Key Colleagues at Startups
The people Adam Craig works with at each company, as listed on that company's latest Form D.
Garuda Therapeutics, Inc. · Form D, Oct 31, 2024
GM
Geoff Meyerson
Director
RK
Raymond Kelleher
Director
EA
Eric Aguiar
Director
SL
Steve Liapis
Director
RS
Rahul Singhvi
Director
DK
David Kirske
Executive officer
CG
Carl Gordon
Director